Performance

Traditional LPs contemplating GP-led focused funds have been intent on identifying examples of fully crystallised continuation funds in recent years.

While it’s still early doors, managers are beginning to shout from the rooftops when it comes to the returns they’ve produced from exiting assets in continuation funds.

Diagnostics business The Binding Site was part of a group of companies involved in the firm's landmark 2018 GP-led secondaries process.

Even amid today’s rocky macro environment, the industry’s biggest fundraisers continue to pull in more capital.

Experts from Greenhill, NewQuest and LGT Capital Partners discuss what’s driving secondaries dealflow in Asia-Pacific this year.

Buyers are showing greater manager selectivity but are willing to pay for quality, a Palico spokesperson said.

Private equity performance has held relatively steady compared with the pain in the public markets so far this year. That may start changing over the new few weeks.

While initial secondaries volume estimates point to a record first half, expectations for full-year 2022 may have to be revised downward.

The deal totalled somewhere in the range of $2bn to $2.5bn, making it one of the largest deals of the year.

The firm has seen several examples of transactions that it previously passed on being relaunched with refreshed pricing.